Immutable evidence record · ticker
Liminatus Pharma, Inc. Class A Common Stock (LIMN)
Published as observed on 20 August 2026 at 17:35 BST.
Liminatus Pharma, Inc. Class A Common Stock has a balanced company news read. Its latest completed weekly trend is negative.
- As of
- 20 Aug 2026, 17:35
- Scope
- company and instrument
- Evidence
- 22 items
- Independent sources
- 2
- Country
- United States
- Sector
- Healthcare
- Previous read
- 50.000
- Change
- —
Verification
Evidence & related research
Company chart →Technicals & Market Dynamics →Technical Research Pack →Company news sentiment →Current financial news →
This is dated market research. Coverage may be delayed, incomplete or unavailable.
Cite this record:
Sharemaestro, Liminatus Pharma, Inc. Class A Common Stock (LIMN), 2026-08-20, https://sharemaestro.com/evidence/cee4893f-8797-455e-96cc-e4bb08189d0e/
Record checksum c047237c0e082bd0030aa09aa7dd91f9b1df78b3cef9726cec5923d393512674
